Health Improvement for Baltimore Youth
NCT02624193, Not applicable, Completed, Johns Hopkins University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Health Improvement for Baltimore Youth | ClinicalTrials.gov |
| NCT number | NCT02624193 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 97 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Johns Hopkins University | ClinicalTrials.gov |
| Conditions | HIV, Adolescent Development, Adolescent Behavior, Medication Adherence | ClinicalTrials.gov |
| Interventions | MBSR Program, HT Program | ClinicalTrials.gov |
| First posted | 2015-12-08 | ClinicalTrials.gov |
| Last updated | 2018-10-31 | ClinicalTrials.gov |
Registered outcomes 29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Treatment Adherence | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on treatment adherence as measured by the Adolescent Medicine Trials Network (ATN) HIV Medication Adherence self-report measure, as well as CD4 and viral load counts pulled from the participant's medical record. The measure and medical record data collection takes place at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | NIH Emotion Measures Questionnaire | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. Specific NIH emotion measures are: meaning \& purpose, positive affect, anger, fear, perceived hostility, sadness. | ClinicalTrials.gov |
| Secondary | Illness Cognition (IC) Scale | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on thoughts of illness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Difficulties in Emotion Regulation Scale (DERS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on issues in emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Mindful Acceptance and Awareness Scale (MAAS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Five Facet Mindfulness Questionnaire (FFMQ) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on multiple aspects of mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Differential Emotions Scale (DES) - selected items | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on frequency of emotions (specifically, self-hostility, shame, shyness, and guilt) measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | State-Trait Anger Expressivity Inventory (STAXI) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on anger expression measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Children's PTSD Symptom Severity Checklist (CPSS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on trauma symptoms measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Compassion Scale | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on self-compassion measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Perceived Stress Scale (PSS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on perceived stress measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Sex Risk Scale | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on risky sexual behavior measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Lesbian & Gay Identity Scale (LGIS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on self-acceptance of lesbian/gay/bisexual identity measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | General Health Assessment | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on general health measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Youth Quality of Life scale (YQOL) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on quality of life measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Brief COPE Questionnaire | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on coping measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Children's Response Style Questionnaire (CRSQ) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on coping responses measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Das-Naglieri Cognitive Assessment System (CAS) | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Secondary | Emotion Stroop Task | Baseline, and follow up at 3, 6, and 12 months | Assessment of impact of MBSR versus HT on emotion-based cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
| Other | Berkeley Expressivity Questionnaire (BEQ) | Baseline, and follow up at 3, 6, and 12 months | For those selected to be in the supplement study, assessment of impact of MBSR versus HT on emotion expressivity (by gender) measured at baseline, post-program (3-month follow up), 6-month follow-up, and 12-month follow-up. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|---|---|---|---|---|---|
| R01AT007888 | Improving Treatment Adherence in HIV-Positive Youth Through Mindfulness Training | SIBINGA, ERICA | JOHNS HOPKINS UNIVERSITY | NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH | 2013 to 2017 | NIH RePORTER |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Dimensional Change Card Sort | Other outcome | ConductCognition |
| Picture Order Memory Test | Other outcome | ConductCognition |
| Size Order Memory Test | Other outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)